Oryzon Genomics SA Financial Overview
Oryzon Genomics SA's market cap is currently €250.75M. The company's EPS TTM is €-0.009; its P/E ratio is -72.79; Oryzon Genomics SA is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is €-0.03. See an overview of income statement, balance sheet, and cash flow financials.
